Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,754,460
+$94,869 QoQ
Shares Held
10,368
-0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#962
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOSTON FAMILY OFFICE LLC holds $74,645,423 across 10 Drug Manufacturers - General names. AMGN ranks #5 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,325 | $21,979,556 | |
| 2 | ABBV |
AbbVie Inc.
|
69,593 | $17,512,382 | |
| 3 | JNJ |
Johnson & Johnson
|
68,219 | $17,325,579 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,081 | $5,535,908 | |
| 5 | AMGN |
Amgen Inc
This page
|
10,368 | $3,754,460 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
16,037 | $2,026,114 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,077 | $1,790,656 | |
| 8 | NVO |
Novo Nordisk A S
|
36,941 | $1,770,951 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,754,460 | 10,368 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,659,591 | 10,401 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,000,450 | 9,167 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,588,902 | 9,174 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,544,161 | 9,112 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,509,846 | 8,056 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,146,109 | 8,234 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,694,964 | 8,364 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,629,579 | 8,416 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,407,621 | 8,468 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,452,490 | 8,515 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,311,067 | 8,599 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,882,729 | 8,480 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,031,183 | 8,402 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,243,470 | 8,542 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,988,253 | 8,821 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,287,020 | 9,400 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,302,126 | 9,520 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,100,094 | 9,335 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,974,242 | 9,284 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,265,412 | 9,294 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,312,440 | 9,294 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,368,405 | 10,301 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,618,102 | 10,301 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,523,466 | 10,699 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,214,622 | 10,924 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||